XBI
ETF
Biotechnology
NYSEARCA
SPDR S&P Biotech ETF
$126.74
+1.14 (+0.91%)
Fund Overview
by SPDR (State Street)
Equal-weighted biotech ETF. Gives small-cap clinical-stage biotech companies equal weight with large-cap pharma-like biotechs, creating a higher risk/reward profile. When biotech M&A heats up, XBI often outperforms.
AUM$6.5B
Expense Ratio0.35%
Holdings145
Dividend Yield0.1%
DistributionQuarterly
BenchmarkS&P Biotechnology Select Industry Index
InceptionJan 2006
ExchangeNYSEARCA
Price Data
Open$124.75
Prev Close$125.60
Day Range$123.43 — $126.79
Investment Calculator
See how much dividend income XBI could generate based on its current price of $126.74 and 0.1% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,885.72
Annual Income$9.89
Monthly Income$0.82
Based on current dividend yield of 0.1%. Actual distributions may vary. Past dividends do not guarantee future payments.
Biotechnology ETF Comparison
Top Biotechnology Stocks
View all →
| Stock | Price | Change | Market Cap |
|---|---|---|---|
| ABBV | $228.72 | -1.78% | 397.77B |
| AMGN | $375.50 | -1.11% | 203.62B |
| GILD | $151.12 | -1.06% | 187.49B |
| VRTX | $469.27 | -0.22% | 124.10B |
| REGN | $782.38 | -1.23% | 82.83B |
| ALNY | $340.11 | +0.22% | 43.84B |
| INSM | $149.86 | -0.77% | 33.81B |
| NTRA | $216.71 | +0.16% | 29.93B |
| BIIB | $201.18 | +8.53% | 28.17B |
| UTHR | $475.11 | -1.13% | 20.54B |
XBI FAQ
What is XBI?
XBI is the SPDR S&P Biotech ETF, an exchange-traded fund managed by SPDR (State Street). It tracks the S&P Biotechnology Select Industry Index and holds 145 Biotechnology securities with an expense ratio of 0.35%.
What is the expense ratio of XBI?
XBI charges an annual expense ratio of 0.35%, which means you pay $35.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does XBI pay dividends?
Yes, XBI pays a 0.1% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $10.00 per year in dividend income.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
Last updated: Feb 20, 2026 at 3:10 PM ET